关注
Graham Leggatt
Graham Leggatt
University of Queensland Diamantina Institute
在 uq.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Selective expansion of high-or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.
MA Alexander-Miller, GR Leggatt, JA Berzofsky
Proceedings of the National Academy of Sciences 93 (9), 4102-4107, 1996
6531996
Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity
P Bhat, G Leggatt, N Waterhouse, IH Frazer
Cell death & disease 8 (6), e2836-e2836, 2017
4792017
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives
NA Saunders, F Simpson, EW Thompson, MM Hill, L Endo‐Munoz, ...
EMBO molecular medicine 4 (8), 675-684, 2012
3052012
Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL.
MA Alexander-Miller, GR Leggatt, A Sarin, JA Berzofsky
The Journal of experimental medicine 184 (2), 485-492, 1996
2791996
Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell
FG Gao, V Khammanivong, WJ Liu, GR Leggatt, IH Frazer, GJP Fernando
Cancer research 62 (22), 6438-6441, 2002
2082002
Potential strategies utilised by papillomavirus to evade host immunity
IH Frazer, R Thomas, J Zhou, GR Leggatt, L Dunn, N McMillan, RW Tindle, ...
Immunological reviews 168 (1), 131-142, 1999
1681999
RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin
LN Putral, MJ Bywater, W Gu, NA Saunders, BG Gabrielli, GR Leggatt, ...
Molecular pharmacology 68 (5), 1311-1319, 2005
1622005
Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes
W Gu, L Putral, K Hengst, K Minto, NA Saunders, G Leggatt, NAJ McMillan
Cancer gene therapy 13 (11), 1023-1032, 2006
1612006
The role of CXCR3 and its chemokine ligands in skin disease and cancer
PT Kuo, Z Zeng, N Salim, S Mattarollo, JW Wells, GR Leggatt
Frontiers in medicine 5, 271, 2018
1572018
Prevention and treatment of papillomavirus-related cancers through immunization
IH Frazer, GR Leggatt, SR Mattarollo
Annual review of immunology 29 (1), 111-138, 2011
1412011
Serological evaluation of the 12 kDa subunit of antigen B in Echinococcus granulosus cyst fluid by immunoblot analysis
GR Leggatt, W Yang, DP McManus
Transactions of the Royal Society of Tropical Medicine and Hygiene 86 (2 …, 1992
1201992
Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy
WJ Liu, KN Zhao, FG Gao, GR Leggatt, GJP Fernando, IH Frazer
Vaccine 20 (5-6), 862-869, 2001
1142001
Regulation of immune responses to HPVinfection and during HPV‐directed immunotherapy
P Bhat, SR Mattarollo, C Gosmann, IH Frazer, GR Leggatt
Immunological reviews 239 (1), 85-98, 2011
982011
Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes
WJ Liu, XS Liu, KN Zhao, GR Leggatt, IH Frazer
Virology 273 (2), 374-382, 2000
962000
Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment
T Kobayashi, PY Lam, H Jiang, K Bednarska, R Gloury, V Murigneux, ...
Blood, The Journal of the American Society of Hematology 136 (26), 3004-3017, 2020
942020
Chimeric human papilloma virus–simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques
CJ Dale, XS Liu, R De Rose, DFJ Purcell, J Anderson, Y Xu, GR Leggatt, ...
Virology 301 (1), 176-187, 2002
842002
Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors
K Matsumoto, GR Leggatt, J Zhong, X Liu, RL de Kluyver, T Peters, ...
Journal of the National Cancer Institute 96 (21), 1611-1619, 2004
792004
IL-10 mediates suppression of the CD8 T cell IFN-γ response to a novel viral epitope in a primed host
XS Liu, Y Xu, L Hardy, V Khammanivong, W Zhao, GJP Fernando, ...
The Journal of Immunology 171 (9), 4765-4772, 2003
722003
Tolerance or immunity to a tumor antigen expressed in somatic cells can be determined by systemic proinflammatory signals at the time of first antigen exposure
IH Frazer, RD Kluyver, GR Leggatt, H Yang Guo, L Dunn, O White, ...
The Journal of Immunology 167 (11), 6180-6187, 2001
692001
HPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2-and CCL5-mediated recruitment of mast cells
AS Bergot, N Ford, GR Leggatt, JW Wells, IH Frazer, MA Grimbaldeston
PLoS pathogens 10 (10), e1004466, 2014
682014
系统目前无法执行此操作,请稍后再试。
文章 1–20